a strong trendP < .011
There was a strong trend toward a significant improvement in pain in those who had a partial or complete response to the KS ( P < .011).
There was a strong trend toward a significant improvement in pain in those who had a partial or complete response to the KS ( P < .011).
There was a possible trend toward an association between greater cumulative SAEs and improved GHS at month 12 ( P = .08), suggesting short-term chemotherapy-related adverse events may have been balanced by 12-month KS outcomes.